Business Standard

Kilitch Drugs (India) Share Price

Know More

361.55 33.25 (10.13%)

19th Jul 2024

360.55 32.45 (9.89%)

19th Jul 2024

BSE : 524500


Sector : Health care

ISIN Code : INE729D01010

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 19-Jul-2024

Market Cap (₹ Cr)


Traded Value (₹ Cr)


Volume (Shares)


Face Value (₹)


52-Week High (₹)


52-Week High Date


52-Week Low (₹)


52-Week Low Date


All Time High (₹)


All Time High Date


All Time Low (₹)


All Time Low Date


Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Limited (KDIL) was incorporated in May 1992 as a public limited company. The Company is a pharmaceutical company engaged in development manufacturing and marketing of quality finished dosages. The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia. Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid liquid and parenteral forms of creating safe pharmaceutical solutions.The Company went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture phar...
Read More

Kilitch Drugs (India) Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [C]


P/E Ratio (X) [C]


Face Value (₹) 10
Latest Dividend (%)5.00
Latest Dividend Date 20-Sep-2019
Dividend Yield (%) -
Book Value Share (₹) [C]109.62
P/B Ratio (₹) [C]3.29

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)



Week Low/High (₹)



Month Low/High (₹)



Year Low/High (₹)



All time Low/High (₹)



Share Price Returns

1 Week6.85%6.56%0.110.12%
1 Month12.81%12.69%4.224.32%
3 Month3.99%3.65%10.2810.76%
6 Month-8.50%-8.76%12.4513.45%
1 Year95.21%93.43%20.1323.69%
3 Year112.65%112.15%53.3855.73%

Company Info

Company Information

Chairman & Managing Director : Mukund P Mehta

Whole-time Director : Bhavin M Mehta

Independent Director : Hemang Engineer

Whole-time Director : Mira Bhavin Mehta

Independent Director : Murti Vasudev Krishna

Independent Director : Venkita Subramanian Rajan

Company Sec. & Compli. Officer : Pushpa Nyoupane

Registered Office: C-301/2 MIDC TTC Indl Area, Pawane Village,Thane,Maharashtra-400705 Ph: 91-022-27670322/27680913/65144185


FAQs about Kilitch Drugs (India) Ltd

1. What's the Kilitch Drugs (India) Ltd share price today?
Kilitch Drugs (India) Ltd share price was Rs 361.55 at close on 19th Jul 2024. Kilitch Drugs (India) Ltd share price was up by 10.13% over the previous closing price of Rs 328.30. Kilitch Drugs (India) Ltd share price trend:

  • Last 1 Month: Kilitch Drugs (India) Ltd share price moved up by 12.81% on BSE
  • Last 3 Months: Kilitch Drugs (India) Ltd share price moved up by 3.99% on BSE
  • Last 12 Months: Kilitch Drugs (India) Ltd share price moved up by 95.21% on BSE
  • Last 3 Years: Kilitch Drugs (India) Ltd price moved up by 112.65% on BSE

2. How can I quickly analyse the performance of the Kilitch Drugs (India) Ltd stock?
The performance of the Kilitch Drugs (India) Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 39.71
  • Price to book value ratio is 3.29
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Kilitch Drugs (India) Ltd stock is Rs 9.08

3. What is the market cap of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd has a market capitalisation of Rs 581 crore.

4. What is Kilitch Drugs (India) Ltd's 52-week high/low share price?
The Kilitch Drugs (India) Ltd’s 52-week high share price is Rs 469.85 and 52-week low share price is Rs 175.00.

5. Is the Kilitch Drugs (India) Ltd profitable?
On a consolidated basis, Kilitch Drugs (India) Ltd reported a profit of Rs 3.64 crore on a total income of Rs 40.04 crore for the quarter ended 2024. For the year ended Mar 2024, Kilitch Drugs (India) Ltd had posted a profit of Rs 3.68 crore on a total income of Rs 45.29 crore.

6. Which are Kilitch Drugs (India) Ltd’s peers in the Health care sector?
Kilitch Drugs (India) Ltd’s top 5 peers in the Health care sector are Fermenta Biotec., Nectar Lifesci., Wanbury, Kilitch Drugs, Valiant Laborato, Medicamen Biotec, Vikram Thermo.

7. Who owns how much in Kilitch Drugs (India) Ltd?
Key changes to the Kilitch Drugs (India) Ltd shareholding are as follows:

  • Promoter holding in Kilitch Drugs (India) Ltd has gone up to 69.23 per cent as of Jun 2024 from 69.23 per cent as of Sep 2023.